Immunoglobulin deficient rats as donors and recipients of effector cells of allergic encephalomyelitis
- PMID: 2419359
- DOI: 10.1016/0165-5728(86)90111-6
Immunoglobulin deficient rats as donors and recipients of effector cells of allergic encephalomyelitis
Abstract
Lewis rats, treated from birth with a rabbit anti-rat IgM antiserum are B-cell and immunoglobulin deficient. When sensitized with myelin basic protein (BP) and complete Freund's adjuvant (CFA), these rats do not make detectable antibodies to BP, nor do they develop clinical or histopathological evidence of allergic encephalomyelitis (EAE). We show here that transfer of anti-BP antibody containing serum to BP sensitized Ig deficient rats results in subsequent development of EAE. We also demonstrate that BP sensitized Ig deficient rats which do not develop EAE, nevertheless generate effector cells capable of transferring disease, and thus specific T-cell function is not inhibited by the anti-Ig treatment. Finally, Ig deficient rats were shown to be perfectly adequate recipients of passively induced EAE.
Similar articles
-
Immunoglobulin-deficient rats fail to develop experimental allergic encephalomyelitis.J Neuroimmunol. 1983 Oct;5(2):99-109. doi: 10.1016/0165-5728(83)90001-2. J Neuroimmunol. 1983. PMID: 6194180
-
Suppression of experimental allergic encephalomyelitis with thoracic duct lymphocytes.Int Arch Allergy Appl Immunol. 1980;63(2):153-8. doi: 10.1159/000232621. Int Arch Allergy Appl Immunol. 1980. PMID: 6158482
-
Suppression of experimental allergic encephalomyelitis by transfer of lymph node cells from Lewis rats pretreated with complete Freund's adjuvant.Int Arch Allergy Appl Immunol. 1981;66(3):326-31. doi: 10.1159/000232837. Int Arch Allergy Appl Immunol. 1981. PMID: 6170593
-
Liposomes containing myelin basic protein (BP) suppress but do not induce allergic encephalomyelitis in Lewis rats.Aust J Exp Biol Med Sci. 1981 Apr;59(Pt 2):135-41. doi: 10.1038/icb.1981.9. Aust J Exp Biol Med Sci. 1981. PMID: 6167253
-
Neuroimmunologic diseases: effector cell responses and immunoregulatory mechanisms.Immunol Rev. 1981;55:89-120. doi: 10.1111/j.1600-065x.1981.tb00340.x. Immunol Rev. 1981. PMID: 6165674 Review. No abstract available.
Cited by
-
Treating human autoimmune disease by depleting B cells.Ann Rheum Dis. 2002 Oct;61(10):863-6. doi: 10.1136/ard.61.10.863. Ann Rheum Dis. 2002. PMID: 12228152 Free PMC article. Review. No abstract available.
-
Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice.J Exp Med. 1996 Dec 1;184(6):2271-8. doi: 10.1084/jem.184.6.2271. J Exp Med. 1996. PMID: 8976182 Free PMC article.
-
Immunochemical specificity of antisera raised against the synthetic encephalitogenic peptide SH624, residues 59-74 of the myelin basic protein.Neurochem Res. 1987 Jan;12(1):9-14. doi: 10.1007/BF00971357. Neurochem Res. 1987. PMID: 2437472
-
Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease.Proc Natl Acad Sci U S A. 2016 Mar 22;113(12):3323-8. doi: 10.1073/pnas.1519608113. Epub 2016 Mar 8. Proc Natl Acad Sci U S A. 2016. PMID: 26957602 Free PMC article.
-
A case for regulatory B cells in controlling the severity of autoimmune-mediated inflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.J Neuroimmunol. 2011 Jan;230(1-2):1-9. doi: 10.1016/j.jneuroim.2010.10.037. Epub 2010 Dec 10. J Neuroimmunol. 2011. PMID: 21145597 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources